Home › Taiwan Mid-Cap 100 Companies › PELL BIO-MED TECHNOLOGY CO., LTD.
PELL BIO-MED TECHNOLOGY CO., LTD. mainly engages in chimeric antigen receptor T-cell (CAR-T) therapy and cell products under the Special Management Regulations for cell therapy. The company was established in 2017 and was listed on the Taiwan Stock Exchange Innovation Board in 2024. Industry category: Biotechnology and Medical Care.
Biotechnology and Medical CareCaliway Biopharmaceuticals Co., Ltd. is a new drug development company focused on new drug development in medical aesthetics and chronic inflammatory diseases, and also develops health foods. Founded in 2012, the company was listed on the Taiwan Stock Exchange in 2024. Industry category: Biotechnology and Medical Care.